$240,000 of OLIN CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to asbestos; Issues related to reform of the Frank R. Lautenberg Chemical Safety for the 21st Century Act (PL 114-182); Issues related to the Epoxy Resin anti-dumping and countervailing duty cases pending at International Trade Commission. Issues related to railroad safety. Issues related to Department of Defense and NDAA appropriations pertaining to the Lake City Funding Provision."
You can find more data on corporate lobbying on Quiver Quantitative.
OLN Insider Trading Activity
OLN insiders have traded $OLN stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OLN stock by insiders over the last 6 months:
- KENNETH TODD LANE (President & CEO) purchased 7,250 shares for an estimated $203,446
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OLN Hedge Fund Activity
We have seen 190 institutional investors add shares of OLN stock to their portfolio, and 180 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOSTON PARTNERS removed 3,790,241 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $91,875,441
- PACER ADVISORS, INC. removed 2,817,419 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $68,294,236
- FULLER & THALER ASSET MANAGEMENT, INC. added 1,840,900 shares (+40.5%) to their portfolio in Q1 2025, for an estimated $44,623,416
- CITADEL ADVISORS LLC added 1,641,751 shares (+1428.2%) to their portfolio in Q1 2025, for an estimated $39,796,044
- UBS GROUP AG removed 1,556,825 shares (-80.8%) from their portfolio in Q1 2025, for an estimated $37,737,438
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 1,259,795 shares (+11.5%) to their portfolio in Q1 2025, for an estimated $30,537,430
- MILLENNIUM MANAGEMENT LLC removed 1,057,222 shares (-33.0%) from their portfolio in Q1 2025, for an estimated $25,627,061
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
OLN Analyst Ratings
Wall Street analysts have issued reports on $OLN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 05/12/2025
- Keybanc issued a "Overweight" rating on 04/14/2025
- Citigroup issued a "Buy" rating on 03/27/2025
To track analyst ratings and price targets for OLN, check out Quiver Quantitative's $OLN forecast page.
OLN Price Targets
Multiple analysts have issued price targets for $OLN recently. We have seen 13 analysts offer price targets for $OLN in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $24.0 on 07/15/2025
- Aleksey Yefremov from Keybanc set a target price of $32.0 on 07/14/2025
- Joshua Spector from UBS set a target price of $23.0 on 07/09/2025
- Patrick Cunningham from Citigroup set a target price of $25.0 on 07/08/2025
- Arun Viswanathan from RBC Capital set a target price of $23.0 on 07/03/2025
- Michael Leithead from Barclays set a target price of $24.0 on 05/28/2025
- Angel Castillo from Morgan Stanley set a target price of $20.0 on 05/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
